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Abstract
The beneficial effect of dietary n-3 polyunsaturated fatty acids (PUFAs) on developing hypertension has been repeatedly demonstrated.
However, related changes in brain membrane composition and its cognitive correlates have remained unclear. Our study aimed at a
comprehensive analysis of behavior and cerebral fatty acid concentration in hypertension after long-term PUFA-rich dietary treatment.
Hypertensive and normotensive rats were provided a placebo, or one of two PUFA-enriched diets with a reduced (n-6) /(n-3) ratio for 75
weeks. Exploratory behavior and spatial learning capacity were tested. Systolic blood pressure (BP) was repeatedly measured. Finally,
brain fatty acid composition was analyzed by gas chromatography. Hypertensive rats exhibited more active exploration but impaired
spatial learning compared to normotensives. Both diets reduced BP, increased PUFA and monounsaturated fatty acid (MUFA)
concentration, and reduced saturated fatty acid content in brain. The level of cerebral PUFAs and MUFAs was lower in hypertensive than
in normotensive rats. Furthermore, BP positively, while spatial learning negatively correlated with cerebral (n-6) /(n-3) PUFA ratio. We
concluded that regular n-3 PUFA consumption could prevent the development of hypertension, but reached only a very delicate
improvement in spatial learning. Furthermore, we consider a potential role of metabolically generated MUFAs in the beneficial effects of
PUFA supplementation.
  2003 Elsevier B.V. All rights reserved.
Theme: Development and regeneration
Topic: Nutritional and prenatal factors
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1 . Introduction decrease coronary heart disease, and suppress cardiac
arrhythmia [3,12,16,21,22,26,29,31,34,35]. In particular,
The cardiovascular protective effects of long chain n-3 eicosapentaenoic acid (EPA, 20:5 n-3) and docosahex-
polyunsaturated fatty acids (PUFAs) derived from fish oil aenoic acid (DHA, 22:6 n-3) were identified as the
have been repeatedly demonstrated by both human epi- biologically active n-3 PUFA constituents in fish oil, of
demiological and experimental animal studies. The con- which DHA emerged as the potentially more effective
sumption of an n-3 PUFA rich diet was shown to success- substance [26,29].
fully reduce blood pressure in developing hypertension, Besides moderating hypertension, dietary n-3 PUFA
intake in spontaneously hypertensive rats (SHRs) was
shown to change tissue phospholipid composition in
*Corresponding author. Department of Animal Physiology, Workgroup
several organs including the brain [11,12,43,45]. After
of Molecular Neurobiology, University of Szeged, P.O. Box 427, Szeged
dietary treatment with perilla oil or linseed oil rich in theH-6701, Hungary. Tel.: 136-62-545-669; fax: 136-62-545-707.
E-mail address: farkase@anat-fm.szote.u-szeged.hu (E. Farkas). essential alpha-linolenic acid (ALA, 18:3 n-3), the (n-6) /
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T able 1(n-3) PUFA ratio in SHR brain membranes followed the
The source of fatty acid additives and polyunsaturated fatty acid contentratio in the diets, and was reduced accordingly [11,43].
of the experimental diets (g /100 g)Interestingly, the balance between n-3 and n-6 PUFAs in
Component Control Diet 1 Diet 2cerebral membranes appeared to influence brain function,
especially learning and memory processes. Normotensive Soybean oil 5 2.5 2.5
(Florin, Switzerland)rodents chronically supplemented with n-3 PUFA-enriched
diets demonstrated enhanced spatial learning, which was Marinol C45 (source of EPA and DHA) – 2.15 2.15
(Loders Crocklaan, The Netherlands)accompanied by elevated brain DHA content [37,48]. The
authors proposed that the changes in brain fatty acid Ropufa 50 (source of AA) – 0.35 0.35
composition could modify membrane fluidity by decreas- (Roche, The Netherlands)
ing cholesterol level, which probably accounted for en- Fatty acids
hanced cognition [47,48]. At the same time, other studies 18:2 n-6 (LA) 0.640 1.321 1.661
20:4 n-6 (AA) 0.000 0.118 0.118also demonstrated that n-3 PUFA feeding increased neuro-
Total n-6 0.640 1.439 1.779transmitter receptor density for dopamine and acetylcho-
18:3 n-3 (ALA) 0.155 0.137 0.184line [4,14], both known for their prominent role in learning 20:5 n-3 (EPA) 0.000 0.589 0.589
and memory processes. 22:6 n-3 (DHA) 0.000 0.382 0.382
In the present study, we aimed at identifying the Total n-3 0.155 1.108 1.155
(n-6) /(n-3) 4.13 1.30 1.54behavioral correlates of alleviated hypertension after
chronic n-3 PUFA-enriched dietary treatment of SHRs.
Since spatial learning performance of SHR animals ap-
animals were first group-housed in cages of five, and
peared to be impaired [17,30], we postulated that dietary
moved to individual cages at the age of 24 weeks, when
n-3 PUFA supplementation could improve memory capaci-
spatial learning testing started. The rats were following the
ty not only by relieving hypertension, but also by being given nutritional regimes from 4 to 80 weeks of age, and
incorporated into cerebral membranes. In order to tackle
were offered food and water ad libitum except the periods
the parallel vascular and behavioral effects of n-3 PUFA
of the holeboard learning test, when food restriction was
feeding in SHRs, we measured systolic blood pressure, imposed. The animals were weighed weekly during the
assessed behavioral profile and analyzed fatty acid com-
entire experiment and daily during the period of food
position of cerebral membranes. Further, the different read-
restriction (Fig. 1).
outs were correlated to unravel a potential, individual
relationship between brain membrane composition, learn- 2 .3. Blood pressure measurement
ing capacity and blood pressure in alleviated hypertension.
Systolic blood pressure (BP) was repeatedly measured
by the tail-cuff method [5,27] at the ages of 53, 54, 55, and
2 . Materials and methods 79 weeks. The rats were lightly anesthetized by isoflurane
gas. Blood pressure was measured in each case three
2 .1. Dietary design
consecutive times and the values were averaged.
The experimental diets were similar to those used in
T able 2previous studies [8,14]. The control food was essentially
Additional supplements of the experimental diets (g /100 g)identical to the standard rat chow produced by Hope Farms
(Woerden, The Netherlands). All three diets consisted of Nutrient Component Control Diet 1 Diet 2
the same amount of carbohydrates, proteins and minerals Antioxidants b-Carotene 0.02 0.02
and contained the same calorie value. Diet 1 and Diet 2 and vitamins Flavonoids 0.2 0.2
Folate 0.0004 0.001 0.001were enriched by PUFAs, antioxidants, vitamins and
Selenium 0.000019 0.00004 0.00004particular extra additives. Table 1 shows the source of fatty
Vitamin B6 0.00153 0.00172 0.00172
acid additives and PUFA contents of the diets, while Table Vitamin B12 0.00005 0.00012 0.00012
2 summarizes the types and amounts of the other supple- Vitamin C 0.2 0.2
ments. Vitamin E 0.0063 0.3 0.3
Other L-Acetylcarnitin 0.62 .2. Experimental groups
Choline 0.15 0.15 0.4
Phosphatidylcholine 0.2
Male SHRs and normotensive Wistar–Kyoto (WKY) Phosphatidylserine 0.2
rats of 4 weeks of age were purchased from Harlan Co-Q10 0.2
Thiamin 0.002 0.002 0.2Nederland. The rats were randomly assigned to the three
Tyrosine 0.944 0.944 1dietary groups. The combination of rat strains and diets
Tryptophan 0.232 0.232 1produced six experimental groups of 10 animals each. The
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 of four, where chocolate chips could be placed. The rats
were deprived of food 24 h prior to the start of the training,
and had free access to their assigned diets only for 2 h per
day after completing the task. The training started at the
age of 24 weeks with habituation trials on 3 consecutive
days (two trials per day). Subsequently, two training trials
(4 h apart) were performed on 7 consecutive days. During
the training trials, only four pits were baited arranged in a
fixed pattern. The rats had to learn to visit only the baited
holes once during the individual trials. The animals had 3
min to complete the task, or were removed from the
holeboard when all four baited holes were visited. Refer-
ence memory score was calculated for each trial as: [(No.
of visits to baited holes)1(No. of revisits to baited holes3
0.5)] divided by [(42No. of visits to baited holes)1(No.
of visits and revisits to non-baited holes1No. of revisits to
baited holes)]. The scores of the two daily trials were
averaged and corrected for the value of the first training
day. The test was repeated at the age of 41 weeks.
At the age of 44 weeks, the animals were trained in the
Morris water maze spatial memory test [8]. The maze
consisted of a water tank and a square, hidden platform on
a fixed location, 1 cm beneath water level. A video camera
recording the animals’ swimming pattern was directed to a
computer equipped with a videotracking software (EthoVi-
sion 2.0; Noldus, Wageningen, The Netherlands), which
measured swimming distance and time, and also discrimi-
nated a platform area (d548.5 cm). The animals were
trained twice a day on 5 consecutive days during the
acquisition phase. The rats entered the water at four
 
Fig. 1. Growth curves of the experimental groups [F(diet)515.209**,
F(bp)57.947*]. Abbreviations: C: control diet, D1: Diet 1, D2: Diet 2,
HB: holeboard, SHR: spontaneously hypertensive rat strain, WKY:
Wistar–Kyoto rat strain.
2 .4. Behavioral and learning tests
A small open filed paradigm was used for the observa-
tion of spontaneous activity in a new environment. At the
age of 19 weeks, the rats were moved from their home
cage to a small open field (25325330 cm) in a dimly lit
room, and their behavior was followed for 60 min. The
actual behavioral pattern of the individual rats was regis-
tered every 10 s. The following behavioral patterns were
recorded: sniffing, ambulation, digging, rearing, grooming
and immobility. Scores were calculated to represent the
frequency of the exhibited behavioral patterns. The calcu-
lation was carried out for consecutive 10-min time blocks
and for the total 60-min observation period (1 point per
manifested pattern per every 10 s).
Next, the animals were trained in the holeboard spatial
Fig. 2. The systolic blood pressure of the experimental groups [F(diet)5discrimination task. The detailed experimental procedure 41.538**, F(bp)5880.784**, interaction: F539.917**]. Abbreviations:
has been described previously [9,41]. Briefly, the floor of C: control diet, D1: Diet 1, D2: Diet 2, SHR: spontaneously hypertensive
the testing box contained 16 small removable pits in rows rat strain, WKY: Wistar–Kyoto rat strain.
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random starting points, were given 2 min to locate the mm film thickness, Supelco, catalog No. 24131). To
platform, and were allowed to sit on the platform for 15 s. identify peaks, Supelco fatty acid standards were used
The average swimming distance of the two trials was (catalog Nos. 4-7085-U, 4-7015-U). The amount of the
calculated as daily score. A probe trial took place 3 days identified fatty acids was calculated as percentage of the
after the last acquisition trial, where the platform was total amount for each phospholipid class.
removed from the pool. The rats were allowed to swim for
1 min and the time spent in the platform area was recorded
as a measure for retention of the platform location. 2 .6. Statistical analysis
2 .5. Cerebral fatty acid analysis The growth curves, systolic blood pressure values and
the behavioral results were compared by repeated measure-
At the age of 80 weeks, the rats were shortly perfused ment two-way analysis of variance (ANOVA). The Morris
by an ice-cold saline solution of 5.8 mM EDTA following maze probe trial was tested by univariate two-way
deep anesthesia with sodium pentobarbital. Lipids were ANOVA. The brain fatty acid composition was analyzed
extracted from whole brain according to Folch et al. [15]. by a multivariate general linear model two-way ANOVA.
The lipid classes were separated on thin layer chromatog- In all cases, the LSD correction was chosen for the post
raphy plates (20320, Silica G 60) using methyl hoc multiple comparison analysis of dietary effect. We
acetate:isopropanol:chloroform:methanol:0.25% KCl in a used the F values to express the dietary and blood pressure
ratio of 25:25:25:10:9. Lipids were transmethylated in effects [F(diet) and F(bp), respectively], where
presence of absolute methanol containing 5% HCl. Fatty superscripted asterisks indicated significance (P values: *
acid methyl esters were determined by gas chromatography #0.05, ** #0.01). Correlation analysis was performed by
using a NUKOL capillary column (30 m30.32 mm, 0.25 the Pearson one-tailed test.
 
Fig. 3. Graphs of the small open field test. Panels A, B and C show the rearing scores [F(diet)53.743*, F(bp)56.916*], while panels D, E and F
demonstrate the immobility scores [F(diet)53.763*, F(bp)51.649]. Abbreviations: C: control diet, D1: Diet 1, D2: Diet 2, SHR: spontaneously
hypertensive rat strain, WKY: Wistar–Kyoto rat strain.
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3 . Results cant in the first session. Post hoc analysis revealed a
specific effect of Diet 2 alone. In the water maze, adult
The systolic BP of adult SHRs (53–55 weeks) on SHRs performed significantly worse than WKY rats both at
control diet was about 50 mmHg higher than that of WKY the acquisition trials [F(bp)571.737**] and the retention
rats. Dietary supplementation did not change the BP of trial [F(bp)517.988**]. Dietary supplementation did not
WKY rats, while both Diet 1 and Diet 2 significantly improve spatial learning in the Morris maze.
reduced BP with 30–50 mmHg in adult SHRs. The dietary Tables 3–5 summarize the hypertension and diet-in-
effect on BP in SHRs diminished with age (79 weeks) duced changes in cerebral fatty acid composition of
(Fig. 2). membrane phospholipids. In summary, saturated fatty acid
Both hypertension and the experimental diets affected content was not affected by blood pressure, but was
spontaneous activity in the small open field. The young remarkably reduced by the experimental diets in the
adult SHRs spent significantly longer time with rearing phosphatidylserine and phosphatidylcholine fractions (16:0
[F(bp)56.916*], grooming [F(bp)515.018**] and digging and 18:0, respectively). The percentage of several n-7 and
[F(bp)522.297**] than the WKY rats. Particularly Diet 2 n-9 MUFA types was lower in SHRs than in WKY rats,
reduced the activity of the animals, which was reflected by and was consistently elevated by the diets. Both n-3 and
less frequent ambulation [F(diet)511.903**], rearing n-6 PUFA content significantly decreased in SHRs com-
[F(diet)53.743*] and grooming [F(diet)53.714*], as well pared to WKY rats most markedly in the phosphatidylino-
as longer periods of immobility [F(diet)53.763*] (Fig. 3). sitol class, while the dietary supplementation considerably
Fig. 4 demonstrates spatial learning in the holeboard. elevated both n-3 and n-6 PUFA concentration. An in-
The learning curves show diet-induced improvement in the crease in total PUFA content was the most consistent
performance of WKY rats, which was statistically signifi- across phospholipid classes. The (n-6) /(n-3) PUFA ratio
was significantly reduced by the diets, most strikingly in
the phosphatidylethanolamine class.
Correlation analysis demonstrated that the (n-6) /(n-3)
 PUFA ratio rather than DHA or AA contents alone
corresponded with BP, which was especially obvious in
SHRs (Fig. 5A). The ratio of (n-6) /(n-3) PUFA in the
phosphatidyethanolamine class stood in direct correlation
with learning score in the holeboard test (Fig. 5B).
4 . Discussion
Our BP measurements verified previous reports that
increased dietary n-3 PUFA content effectively attenuated
the development of hypertension in SHRs [3,12,16]. The
data indicated that the effect was apparent only in adult
SHRs and not in WKY rats, and disappeared at the end of
the animals’ life span. To date, BP changes with respect to
dietary PUFA supplementation were not reported at this
advanced age. We suggest that an age-related, general
failure in BP regulation could have overruled the dietary
effect at 79 weeks.
The SHRs showed more active exploratory behavior in a
novel environment, which had been repeatedly docu-
mented and attributed to increased locomotor activity in
other open field paradigms [7,18,23,39,40]. The lack of
correlation between exploratory behavior and BP also
confirms previous data: although telemetric recording
detected greater pressor response and tachycardia of SHRs
than of WKY rats during exploration, the magnitude of the
Fig. 4. Memory score in the holeboard spatial discrimination test [first autonomic responses appeared to be unrelated to behavior
session: F(diet)53.727*, F(bp)53.094; repeated session: F(diet)52.078, [40].F(bp)51.668]. Abbreviations: C: control diet, D1: Diet 1, D2: Diet 2,
In the present study, Diet 1 led only to a subtleSHR: spontaneously hypertensive rat strain, WKY: Wistar–Kyoto rat
















Fatty acid concentration of brain structural phospholipids in WKY rats
FA type Fatty acids Phospholipid family
PE PS PC PI
WKY-C WKY-D1 WKY-D2 WKY-C WKY-D1 WKY-D2 WKY-C WKY-D1 WKY-D2 WKY-C WKY-D1 WKY-D2
DMA 16:0 5.1660.76 5.7260.74 4.8161.20 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
18:0 6.5661.17 7.3161.22 6.3061.30 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
18:1 n-7 5.3861.00 6.4761.15 5.3061.70 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
18:1 n-9 2.9260.44 2.8660.46 2.4560.77 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
Total DMA 20.0263.29 22.3763.54 18.8664.94 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
SFA 14:0 1.4360.23 1.0060.38 1.1460.47 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
16:0 n.d. n.d. n.d 11.4564.25 4.9061.34 5.0362.12 35.8862.56 37.4261.61 36.2762.11 23.0565.91 15.8464.45 19.8062.13
18:0 14.3163.07 11.9861.53 13.4761.59 33.4064.25 36.0661.48 35.8961.53 17.6762.22 13.9961.18 15.3362.15 28.1566.72 26.2365.05 32.0063.24
22:0 n.d. n.d. n.d. 0.9960.25 1.1960.07 1.0960.14 n.d. n.d. n.d. n.d. n.d. n.d.
Total SFA 15.1763.31 1.2061.23 12.3261.36 45.4667.00 42.1561.65 41.8362.07 53.5562.25 51.4161.79 51.6063.30 11.4964.54 42.0669.04 51.8064.01
MUFA 14:1 n-5 1.2060.23 0.5960.27 0.7660.28 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
16:1 n-7 0.9560.74 1.4960.54 2.1160.70 n.d. n.d. n.d. 1.9360.31 1.4660.26 1.1060.50 3.3460.20 2.7960.94 1.7960.16
18:1 n-7 3.8560.40 4.3860.29 4.2660.22 n.d. n.d. n.d. 6.8960.94 7.8960.70 7.7560.62 2.7160.41 3.2460.44 2.8460.70
18:1 n-9 17.2661.19 17.5260.80 17.0560.48 20.3762.86 27.2962.66 27.1263.85 22.9461.76 24.3661.25 24.0461.50 13.3963.30 9.0862.38 9.4162.52
20:1 n-7 0.6460.59 1.1360.09 1.1560.12 n.d. n.d. n.d. 0.3660.51 1.0060.08 0.8960.37 n.d. n.d. n.d.
20:1 n-9 4.9660.73 4.5860.35 4.8660.39 3.1060.88 3.8960.38 4.0660.52 1.8260.30 1.6060.08 1.7560.16 n.d. n.d. n.d.
22:1 n-9 n.d. n.d. n.d. 0.8860.02 0.6960.13 0.7360.04 n.d. n.d. n.d. n.d. n.d. n.d.
Total MUFA 28.1462.18 29.5061.30 30.0061.68 23.6963.42 31.4462.56 31.6664.22 33.9462.79 36.3162.20 35.5262.22 18.2863.85 15.1162.33 12.4961.99
PUFA 16:3 n-4 1.2260.47 0.9360.13 1.0760.39 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
18:2 n-6 n.d. n.d. n.d. n.d. n.d. n.d. 1.0660.71 1.0460.27 1.0860.57 5.4961.55 2.6361.60 2.7761.06
20:3 n-6 tr. 0.3860.02 0.2960.02 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
20:4 n-6 (AA) 6.9161.17 7.2260.37 7.4360.31 2.4060.71 3.5260.25 3.8860.66 3.9060.52 4.2960.38 4.3160.34 8.8961.92 20.5164.47 20.0065.95
22:4 n-6 3.2560.50 3.1160.22 3.4960.20 1.6860.46 2.2760.23 2.3960.24 n.d. n.d. n.d. n.d. n.d. n.d.
22:5 n-3 tr. 0.5660.06 0.4060.05 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
22:6 n-3 (DHA) 11.7661.72 14.1460.84 13.8160.54 9.6262.60 14.7360.68 14.0761.69 3.9060.60 4.4760.16 4.3560.36 0.8361.45 3.4160.73 4.2961.33
Total PUFA 22.6562.81 25.8261.65 26.0361.30 13.7063.71 20.5261.01 20.3462.48 7.8061.11 8.7660.51 8.6660.69 15.2163.49 26.5664.81 26.6066.16
(n-6) /(n-3) 0.8660.05 0.7360.03 0.7860.02 0.4360.04 0.3960.02 0.4560.03 1.3060.25 1.1960.05 1.2460.13 11.4964.54 7.0261.83 5.3661.12
Rest 14.0365.20 10.3263.10 11.6462.99 17.1565.71 5.8963.58 6.1765.49 4.7264.28 3.5363.16 4.2363.15 15.31610.63 16.28613.99 9.1167.67
Data are given as mean6S.D. Bold face indicates fatty acid types that were manipulated in the experimental diets. Abbreviations: AA: arachidonic acid, C: control diet, D1: Diet 1, D2: Diet 2, DHA:
docosahexaenoic acid, DMA: dimethylacetale (plasminogen-derived), FA: fatty acid, MUFA: monounsaturated fatty acid, n.d.: non-detected, PC: phosphatidylcholine, PE: phosphatidylethanolamine,
















Fatty acid concentration of brain structural phospholipids in SHRs
FA type Fatty acids Phospholipid family
PE PS PC PI
SHR-C SHR-D1 SHR-D2 SHR-C SHR-D1 SHR-D2 SHR-C SHR-D1 SHR-D2 SHR-C SHR-D1 SHR-D2
DMA 16:0 5.7760.82 6.0660.67 5.6460.90 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
18:0 7.0260.58 6.8860.94 6.0760.84 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
18:1 n-7 4.6560.86 5.3560.84 4.9661.19 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
18:1 n-9 2.6260.45 2.5160.39 2.3360.53 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
Total DMA 20.0762.43 20.8062.73 19.0063.23 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
SFA 14:0 1.4660.21 1.0160.37 1.1260.29 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
16:0 n.d n.d n.d 11.7565.58 7.4860.51 6.9462.20 36.8062.27 35.8762.98 33.6662.81 18.6763.95 19.0363.76 17.9864.35
18:0 12.5362.16 13.6061.02 11.9061.55 34.4263.90 37.0464.70 35.0562.49 16.4961.85 15.5160.70 16.0361.38 29.89611.37 27.4565.69 30.1266.82
22:0 n.d n.d n.d 1.0160.14 1.1360.12 1.0960.08 n.d. n.d. n.d. n.d. n.d. n.d.
Total SFA 13.8162.52 14.6961.28 13.0361.60 47.1867.93 45.0864.71 42.9563.54 53.2962.92 51.3962.85 49.6861.98 48.56615.30 46.4869.13 48.10610.54
MUFA 14:1 n-5 1.1360.35 1.0260.57 0.7160.22 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
16:1 n-7 1.1260.22 1.1460.30 1.5660.80 n.d. n.d. n.d. 1.3960.62 1.7860.58 1.5360.32 2.9161.31 3.9061.33 2.4161.38
18:1 n-7 3.2360.29 3.7860.20 3.6860.16 n.d. n.d. n.d. 5.9860.55 6.0760.56 6.0160.24 1.9560.79 2.7360.47 2.5860.52
18:1 n-9 16.6061.58 16.8860.41 17.8260.72 18.0962.64 24.4962.25 22.3262.02 23.7162.08 23.0161.57 23.9661.03 9.3164.42 9.1761.34 7.6362.27
20:1 n-7 0.6460.28 0.9160.10 0.9360.10 n.d. n.d. n.d. 0.5660.25 0.7160.40 0.7360.06 n.d. n.d. n.d.
20:1 n-9 5.2360.73 4.6360.38 5.4560.52 2.8560.74 3.1460.39 3.0560.46 1.6060.15 1.6260.68 1.5560.12 n.d. n.d. n.d.
22:1 n-9 n.d n.d n.d 0.5960.04 tr. 0.6360.08 n.d. n.d. n.d. n.d. n.d. n.d.
Total MUFA 27.6762.42 27.8461.00 30.0661.85 21.0963.02 27.6462.34 25.9362.40 33.2362.14 33.1862.50 33.7761.05 14.1765.78 15.8061.30 12.6262.97
PUFA 16:3 n-4 1.6160.37 1.0560.22 1.1560.38 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
18:2 n-6 n.d n.d n.d n.d n.d n.d 1.0860.50 1.4160.32 1.3760.23 3.4561.92 2.6261.27 2.5061.08
20:3 n-6 0.6160.09 0.4060.18 0.2860.03 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
20:4 n-6 (AA) 7.1360.70 6.6860.42 7.4060.58 2.0260.59 3.1360.47 3.2160.54 4.0660.57 3.4560.15 4.1260.26 5.5461.67 11.2263.67 13.8565.15
22:4 n-6 3.3860.35 2.8360.23 3.4160.32 1.6960.49 1.6160.85 2.0360.27 n.d n.d n.d n.d n.d n.d
22:5 n-3 tr. 0.4060.03 0.3260.07 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
22:6 n-3 (DHA) 11.6161.40 12.7060.77 13.0060.97 8.3562.81 13.9962.54 12.2661.92 3.3860.49 3.2160.28 3.9960.26 0.3960.37 1.1960.75 2.4160.85
Total PUFA 23.6862.01 23.4561.01 25.1562.14 12.0663.86 18.7362.68 17.4962.61 7.4461.03 6.6660.35 8.1060.49 9.3762.26 15.0463.64 18.7565.65
(n-6) /(n-3) 0.9260.05 0.7560.03 0.8360.03 0.4560.03 0.3560.07 0.4360.03 1.5460.22 1.5360.21 1.3860.08 11.7562.74 10.2263.16 7.0461.05
Rest 14.7864.26 13.2363.11 12.7663.24 19.6867.13 8.5668.44 13.6364.83 6.0362.88 8.7865.24 8.4562.62 27.9067.82 22.69610.54 20.52610.07
Data are given as mean6S.D. Bold face indicates fatty acid types that were manipulated in the experimental diets. Abbreviations: AA: arachidonic acid, C: control diet, D1: Diet 1, D2: Diet 2, DHA:
docosahexaenoic acid, DMA: dimethylacetale (plasminogen-derived), FA: fatty acid, MUFA: monounsaturated fatty acid, n.d.: non-detected, PC: phosphatidylcholine, PE: phosphatidylethanolamine,
















Statistical F values of fatty acid concentration analysis in brain structural phospholipids
FA type Fatty acids Phospholipid family
PE PS PC PI
Diet effect BP effect Interaction Diet effect BP effect Interaction Diet effect BP effect Interaction Diet effect BP effect Interaction
Overall effect 34.678** 13.573 0.492 2.140 1.922 5.008* 4.463** 23.438** 3.149** 5.450** 8.741** 2.048*
DMA 16:0 1.723 4.876* 2.567 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
18:0 1.814 0.260 2.414 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
18:1 n-7 2.173 0.584 2.309 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
18:1 n-9 1.565 0.045 2.422 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
Total DMA 2.533 0.229 0.334 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
SFA 14:0 0.744 0.151 1.767 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
16:0 n.d. n.d. n.d. 6.133* 0.949 0.055 2.203 2.346 2.182 0.863 0.015 1.732
18:0 0.208 1.863 4.867* 6.706** 0.838 3.455 7.505** 0.510 2.611 0.906 0.380 0.526
22:0 n.d. n.d. n.d. 0.582 0.311 1.187 n.d. n.d. n.d. n.d. n.d. n.d.
Total SFA 1.811 0.254 4.239* 2.262 1.480 0.109 4.907* 0.958 0.653 1.518 0.040 0.699
MUFA 14:1 n-5 3.523 0.184 1.322 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
16:1 n-7 1.927 4.027 0.328 n.d. n.d. n.d. 2.911 0.303 5.450** 2.496 0.683 1.415
18:1 n-7 8.491** 40.184** 0.551 n.d. n.d. n.d. 3.080 62.868** 2.367 5.667** 2.663 2.112
18:1 n-9 7.946** 0.138 2.270 5.643* 10.158** 0.298 0.737 0.240 1.840 4.313* 2.364 2.371
20:1 n-7 9.335** 23.298** 1.147 n.d. n.d. n.d. 6.899** 0.848 2.368 n.d. n.d. n.d.
20:1 n-9 4.707* 0.541 0.572 0.372 2.769 1.444 0.406 2.238 0.770 n.d. n.d. n.d.
22:1 n-9 n.d. n.d. n.d. 2.320 17.711** 4.736* n.d. n.d. n.d. n.d. n.d. n.d.
Total MUFA 6.106** 1.873 1.008 25.522** 19.288** 0.987 1.286 8.272** 1.166 5.185** 1.295 2.312
PUFA 16:3 n-4 6.721** 0.019 0.010 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
18:2 n-6 n.d. n.d. n.d. n.d. n.d. n.d. 0.553 2.746 0.580 5.025* 3.699 1.633
20:3 n-6 27.375** 0.000 0.289 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
20:4 n-6 (AA) 4.000* 4.359 3.687 3.874* 3.087 0.102 3.132 6.164* 6.381** 17.458** 10.467** 3.068
22:4 n-6 8.574** 4.519 1.424 2.643 1.550 0.236 n.d. n.d. n.d. n.d. n.d. n.d.
22:5 n-3 29.285** 14.520** 1.527 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
22:6 n-3 (DHA) 1.937 10.505** 2.932 9.007** 2.086 0.032 7.552** 40.361** 6.113** 12.194** 20.608** 1.418
Total PUFA 6.764** 1.848 3.303* 24.549** 5.584* 0.179 4.904* 21.061** 6.383** 18.233** 34.797** 1.432
(n-6) /(n-3) 70.381** 16.337** 1.148 14.019** 1.258 3.028 1.834 23.992** 1.331 12.672** 4.140* 1.035
Rest 2.414 2.267 0.398 14.562** 5.442* 0.783 0.302 11.428** 1.209 1.390 9.391** 0.354
Bold face indicates fatty acid types that were manipulated in the experimental diets. Abbreviations: AA: arachidonic acid, BP: blood pressure, C: control diet, D1: Diet 1, D2: Diet 2, DHA:
docosahexaenoic acid, DMA: dimethylacetale (plasminogen-derived), FA: fatty acid, MUFA: monounsaturated fatty acids, n.d.: non-detected, PC: phosphatidylcholine, PE: phosphatidylethanolamine,
PI: phosphatidylinositol, PS: phosphatidylserine, PUFA: polyunsaturated fatty acid, SFA: saturated fatty acid.
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 have been responsible for this effect. The findings corre-
spond with the conclusion of a previous study of ours, that
increasing the dietary n-3 PUFA concentration above daily
requirement, rather than as a compensation for dietary n-3
PUFA deficiency produces no conspicuous effect on the
behavior of rats, when dietary groups are compared [8].
Therefore we propose that n-3 PUFA supplementation to
hypertensives may not directly improve cognitive per-
formance. Instead, n-3 PUFA load can moderate neuronal
damage imposed by hypertension-related, acute cerebro-
vascular events, possibly by combating oxidative stress
[46].
On the other hand, the correlation between spatial
learning performance and the (n-6) /(n-3) PUFA ratio
appeared to demonstrate subtle but sound PUFA-related
improvement in learning capacity. Such correlation analy-
sis appears to be a more sensitive method than group
comparisons to reveal the concealed, dietary PUFA-in-
duced improvement in learning, probably because the
individual variations in spatial memory and brain fatty acid
composition coincide.
The brain fatty acid analysis demonstrated that MUFA
and PUFA concentrations were lower in SHRs than in
WKY rats. Since hypertension is a vascular type of
pathology, altered fatty acid transport through the blood–
brain barrier (BBB) may be one factor to account for the
hypertension-related difference. The endothelial cells of
the BBB selectively transport PUFAs and their precursors,
while the perivascular astrocytes actively participate in the
metabolic elongation of fatty acids [10,28]. Although the
effect of increasing BP on endothelial fatty acid transport
has not been established, hypertension was shown to alter
other carrier-mediated mechanisms like tryptophan and
glutamic acid trafficking, which correlated with brain
content [38]. Furthermore, perivascular astrocytic metabo-
lism was also found to be compromised in hypertensive
rats [44]. Therefore either pressure-induced endothelial
dysfunction at the BBB or exhausted astrocytic metabolism
could lead to reduced MUFA and PUFA content in SHRs.
Fig. 5. (A) Correlation between systolic blood pressure on week 53 and Nevertheless, an alternative explanation may identify an(n-6) /(n-3) PUFA ratio in the phosphatidylethanolamine class of cerebral
elevated lipid peroxidation accompanying high BP as themembranes. Abbreviations: C: control diet, D1: Diet 1, D2: Diet 2, PE:
cause [20,32] since unsaturated fatty acids are particularlyphosphatidylethanolamine, SHR: spontaneously hypertensive rat strain,
WKY: Wistar–Kyoto rat strain. (B) Correlation between holeboard vulnerable for oxidative stress given the presence of less
learning score on day 13 and (n-6) /(n-3) PUFA ratio in the phosphatidyl- stable double bonds in the molecules [33].
ethanolamine class of cerebral membranes. Abbreviations: C: control diet, Dietary PUFA supplementation increased brain PUFAD1: Diet 1, D2: Diet 2, PE: phosphatidylethanolamine, SHR: sponta-
concentration irrespective of specific PUFA type, andneously hypertensive rat strain, WKY: Wistar–Kyoto rat strain.
reduced (n-6) /(n-3) PUFA ratio. These data strongly
correspond with the dietary composition, and reinforce that
dietary fatty acid content is reflected in the phospholipid
structure of cerebral membranes [6,24]. Cerebral MUFA
significantly reduced exploratory behavior. A similar ten- concentration increased while SFA ratio decreased due to
dency was observed in the holeboard in that specifically the experimental diets, the latter possibly on account of
Diet 2 improved learning of WKY rats. Since the com- replacement by PUFA/MUFA.
position of Diet 2 included other additives than PUFAs, Since Diet 1 and Diet 2 were enriched with PUFA at the
the additional supplements, rather than PUFAs alone must expense of MUFA content, the consistent increase of
18 M.C. de Wilde et al. / Brain Research 988 (2003) 9–19
cerebral MUFA level across several subtypes was un- A cknowledgements
expected, and can find explanation only in cellular fatty
acid biochemistry. The elevated MUFA concentration is The study was financed by the Numico Dementia
specially intriguing in the light of the view that olive oil Project No. 98/006 and by Lipidiet EC No. QLRT-2001-
rich in MUFA (18:1 n-9) appears to be protective against 00172.
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(LDL) cholesterol [2,25].
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